TRUE Private Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

TRUE Private Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-86	Closed	-$8K	–	262
2020 Q4	$8K	Hold	86	–	–	﹤0.01%	553
2020 Q3	$5K	Buy	+86	New	+$5.04K	﹤0.01%	557
2018 Q4	–	Sell	-13,265	Closed	-$443K	–	273
2018 Q3	$443K	Buy	13,265 +133	+1%	+$4.21K	0.06%	178
2018 Q2	$381K	Buy	+13,132	New	+$366K	0.06%	187

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SDH

Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRUE Private Wealth Advisors's ARKG Position: Q1 2021 in Review

TRUE Private Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 86 shares — an estimated $8K sold.

TRUE Private Wealth Advisors first reported a position in ARKG in Q2 2018 and held it in 4 quarters. The position peaked at $443K in Q3 2018. 505 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

TRUE Private Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
TRUE Private Wealth Advisors sold 86 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $8K.
TRUE Private Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2018 and held it in 4 quarters.
TRUE Private Wealth Advisors's ARK Genomic Revolution ETF position peaked at $443K in Q3 2018.
505 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.